AOS vs IESC

AOS exhibits mixed financial health with a weak Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score for distress risk assessment. Despite solid profitability metrics like a 28.21% ROE and 18.63% operating margin, the company faces headwinds from declining Q/Q EPS growth (-12.1%) and bearish insider activity. Valuation is stretched relative to Graham's defensive standard ($33.12) but aligns with growth-based intrinsic value ($106.35), while trading below analyst target ($78.27). The stock shows resilience in earnings beats over time, though recent deceleration and technical bearishness temper optimism.

IESC exhibits strong fundamental health with a Piotroski F-Score of 7/9 and an exceptionally low Debt/Equity ratio of 0.07. While the company demonstrates elite profitability (ROE 41.74%) and robust earnings growth (65.8% YoY), the stock is currently trading at a premium, exceeding both its Intrinsic Value ($496.78) and the analyst target price ($458.00). The divergence between stellar operational performance and bearish insider sentiment/technical trends suggests the stock may be overextended after its massive 1-year run (+194.9%).